Offer - Urjas Oil for just ₹ 1 X
Rapamune is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Kidney transplant.
The optimal dosage of Rapamune is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The side effects typically associated with Rapamune include Viral Infection, Anemia, Urinary tract infection. Apart from the aforementioned side effects, Rapamune can also lead to other problems, which have been listed below. Usually, these side effects of Rapamune go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Rapamune's effect during pregnancy is Unknown and Unknown while nursing. Warnings related to Rapamune's effects on the liver, heart and kidney, if any, have been listed below.
Rapamune is contraindicated in people with pre-existing medical conditions like Infections, Lymphoma as it can result in adverse effects. Other conditions have been mentioned below in the Rapamune contraindications section.
Drug interactions for Rapamune have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Rapamune, it is important to know that it is safe while driving, and is habit-forming.
Rapamune is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Rapamune safe for pregnant women?
Side effects of Rapamune during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Rapamune safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Rapamune for breastfeeding women are not known.
What is the effect of Rapamune on the Kidneys?
Rapamune rarely harms the kidneys.
What is the effect of Rapamune on the Liver?
You may experience side effects on your liver after taking Rapamune. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Rapamune on the Heart?
There may be severe side effects of Rapamune on your heart. Do not take it unless a doctor says so.
Rapamune should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rapamune unless your doctor advises you to do so -
Is this Rapamune habit forming or addictive?
Rapamune does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Rapamune will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Rapamune should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Rapamune is not used to treat mental disorders.
Interaction between Food and Rapamune
There is no information on the effects of taking Rapamune with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Rapamune
Information about the interaction of Rapamune and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapamune (sirolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 882
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1140-1143